Suppressing SIRT3 heightened mitochondrial damage, as shown by greater loss of membrane potential and increased ROS levels under hypoxia, and sensitized glioma cells to hypoxia-induced apoptosis [92]. The gene discussed is SIRT3; the disease is central nervous system cancer.